Guilherme V. Silva, MD

Guilherme Vianna Silva, MD, is Director of Structural Heart Disease at Baylor College of Medicine and at The Texas Heart Institute, and Assistant Professor at Baylor College of Medicine.

Dr. Silva is board certified in Cardiovascular Disease, Interventional Cardiology, Internal Medicine, Nuclear Cardiology and Echocardiography.

Show full bio

 

Dr. Silva earned his medical degree from the Federal University of Rio de Janeiro in Brazil in December of 1994. Upon completing his medical degree, he did three years of Cardiology training in Brazil. After coming to the United States, he completed three years of postgraduate training in Internal Medicine at The University of Texas-Houston. At the Texas Heart Institute in Houston, Silva completed four years (June 2003 – June 2007) of fellowship in Research and Adult Cardiology. During his training at the Texas Heart Institute, Dr. Silva held the position of Chief Cardiology Fellow and was given The Tauber Award for the Outstanding Cardiology Fellow of the 2007 graduating class. From July of 2007 to June of 2008, Dr. Silva completed his Interventional Cardiology Fellowship at the Texas Heart Institute and again held the position of Chief Interventional Cardiology Fellow. Finally, Dr. Silva completed a fellowship at the Massachusetts General Hospital/Harvard Medical School in Structural Heart Disease from July 2012 to July 2013.

The major focus of Dr. Silva has been in cardiovascular disease research and is one of the pioneers in the utilization of stem cells for treating heart attacks and heart failure. With over 40 full papers published in the peer-reviewed literature, over 100 abstracts, and 13 books and book chapters along with multiple invitations to teach in the United States and South America are a testimony of his commitment to clinical research and patient care. Dr. Silva’s academic work includes topics such as: stem cell therapy for heart disease, interventional cardiology, coronary imaging, and structural heart disease interventions.

Dr. Silva is an expert in complex interventional cardiology procedures, including; cardiac catheterization, percutaneous transluminal coronary angioplasty (PTCA), coronary stenting, peripheral vascular angioplasty and stenting, and rotational atherectomy. He has also specially trained in structural heart disease interventions and performs procedures such as Transcatheter Aortic Valve Replacement (TAVR), Percutaneous Patent Foramen Ovale (PFO) closure and Percutaneous Atrial septal Defect (ASD) closure and Percutaneous closure of Paraprosthetic Valvular Leaks repairs. Lastly, Dr. Silva also specializes on percutaneous techniques to treat Mitral Valve Disease. He also specializes in MitraClip, a less-invasive treatment option for certain people with mitral regurgitation who are not suitable for surgery.

See Publications

Texas Heart Institute Positions

  • Director, Structural Heart Disease Program, THI Leadership
  • Teaching Staff, Cardiovascular Disease Fellowship
  • Teaching Staff, Interventional Cardiology Fellowship
  • Editorial Consultant, Texas Heart Institute Journal

Interests

  • Cardiology
  • Interventional Cardiology
  • Cardiovascular Disease
  • Structural Heart Disease Interventions

Education

  • Medical School:

    Federal University of Rio de Janeiro

  • Internship:

    University of Texas Health Science Center

  • Residency:

    University of Texas Health Science Center

  • Fellowships:

    Baylor College of Medicine
    Texas Heart Institute

Academic & Clinical Affiliations

  • Baylor College of Medicine
  • Baylor St. Luke's Medical Center

Certifications

  • American Board of Internal Medicine

Honors, Awards and Memberships

Publications

4862227 2K4N54U2 1 alternatives-to-animal-experimentation 10 date desc Silva 2100 https://www.texasheart.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22BTR7H3IJ%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Forrest%20et%20al.%22%2C%22parsedDate%22%3A%222023-05-02%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BForrest%2C%20J.%20K.%2C%20Deeb%2C%20G.%20M.%2C%20Yakubov%2C%20S.%20J.%20et%20al.%20%282023%29.%203-year%20outcomes%20after%20transcatheter%20or%20surgical%20aortic%20valve%20replacement%20in%20low-risk%20patients%20with%20aortic%20stenosis.%20%26lt%3Bi%26gt%3BJ%20Am%20Coll%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B81%26lt%3B%5C%2Fi%26gt%3B%2C%201663%26%23x2013%3B1674.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacc.2023.02.017%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.jacc.2023.02.017%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%223-year%20outcomes%20after%20transcatheter%20or%20surgical%20aortic%20valve%20replacement%20in%20low-risk%20patients%20with%20aortic%20stenosis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20K.%22%2C%22lastName%22%3A%22Forrest%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22G.%20Michael%22%2C%22lastName%22%3A%22Deeb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Steven%20J.%22%2C%22lastName%22%3A%22Yakubov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hemal%22%2C%22lastName%22%3A%22Gada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mubashir%20A.%22%2C%22lastName%22%3A%22Mumtaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Basel%22%2C%22lastName%22%3A%22Ramlawi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tanvir%22%2C%22lastName%22%3A%22Bajwa%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%20S.%22%2C%22lastName%22%3A%22Teirstein%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%22%2C%22lastName%22%3A%22DeFrain%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Murali%22%2C%22lastName%22%3A%22Muppala%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bruce%20J.%22%2C%22lastName%22%3A%22Rutkin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Atul%22%2C%22lastName%22%3A%22Chawla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bart%22%2C%22lastName%22%3A%22Jenson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stanley%20J.%22%2C%22lastName%22%3A%22Chetcuti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Robert%20C.%22%2C%22lastName%22%3A%22Stoler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie-France%22%2C%22lastName%22%3A%22Poulin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kamal%22%2C%22lastName%22%3A%22Khabbaz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%22%2C%22lastName%22%3A%22Levack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kashish%22%2C%22lastName%22%3A%22Goel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Didier%22%2C%22lastName%22%3A%22Tch%5Cu00e9tch%5Cu00e9%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ka%20Yan%22%2C%22lastName%22%3A%22Lam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Pim%20A.%20L.%22%2C%22lastName%22%3A%22Tonino%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Saki%22%2C%22lastName%22%3A%22Ito%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jae%20K.%22%2C%22lastName%22%3A%22Oh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jian%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20J.%22%2C%22lastName%22%3A%22Popma%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neal%22%2C%22lastName%22%3A%22Kleiman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20J.%22%2C%22lastName%22%3A%22Reardon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22Low%20Risk%20Trial%20Investigators%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Randomized%20data%20comparing%20outcomes%20of%20transcatheter%20aortic%20valve%20replacement%20%28TAVR%29%20with%20surgery%20in%20low-surgical%20risk%20patients%20at%20time%20points%20beyond%202%20years%20is%20limited.%20This%20presents%20an%20unknown%20for%20physicians%20striving%20to%20educate%20patients%20as%20part%20of%20a%20shared%20decision-making%20process.%5CnOBJECTIVES%3A%20The%20authors%20evaluated%203-year%20clinical%20and%20echocardiographic%20outcomes%20from%20the%20Evolut%20Low%20Risk%20trial.%5CnMETHODS%3A%20Low-risk%20patients%20were%20randomized%20to%20TAVR%20with%20a%20self-expanding%2C%20supra-annular%20valve%20or%20surgery.%20The%20primary%20endpoint%20of%20all-cause%20mortality%20or%20disabling%20stroke%20and%20several%20secondary%20endpoints%20were%20assessed%20at%203%20years.%5CnRESULTS%3A%20There%20were%201%2C414%20attempted%20implantations%20%28730%20TAVR%3B%20684%20surgery%29.%20Patients%20had%20a%20mean%20age%20of%2074%20years%20and%2035%25%20were%20women.%20At%203%20years%2C%20the%20primary%20endpoint%20occurred%20in%207.4%25%20of%20TAVR%20patients%20and%2010.4%25%20of%20surgery%20patients%20%28HR%3A%200.70%3B%2095%25%5Cu00a0CI%3A%200.49-1.00%3B%20P%5Cu00a0%3D%5Cu00a00.051%29.%20The%20difference%20between%20treatment%20arms%20for%20all-cause%20mortality%20or%20disabling%20stroke%20remained%20broadly%20consistent%20over%20time%3A%20-1.8%25%20at%20year%201%3B%20-2.0%25%20at%20year%202%3B%20and%20-2.9%25%20at%20year%203.%20The%20incidence%20of%20mild%5Cu00a0paravalvular%20regurgitation%20%2820.3%25%20TAVR%20vs%202.5%25%20surgery%29%20and%20pacemaker%20placement%20%2823.2%25%20TAVR%20vs%209.1%25%20surgery%3B%20P%5Cu00a0%26lt%3B%200.001%29%20were%20lower%20in%20the%20surgery%20group.%20Rates%20of%20moderate%20or%20greater%20paravalvular%20regurgitation%20for%20both%20groups%20were%5Cu00a0%26lt%3B1%25%20and%20not%20significantly%20different.%20Patients%20who%20underwent%20TAVR%20had%20significantly%20improved%20valve%20hemodynamics%20%28mean%20gradient%209.1%5Cu00a0mm%5Cu00a0Hg%20TAVR%20vs%2012.1%5Cu00a0mm%5Cu00a0Hg%20surgery%3B%20P%5Cu00a0%26lt%3B%200.001%29%20at%203%20years.%5CnCONCLUSIONS%3A%20Within%20the%20Evolut%20Low%20Risk%20study%2C%20TAVR%20at%203%20years%20showed%20durable%20benefits%20compared%20with%20surgery%5Cu00a0with%20respect%20to%20all-cause%20mortality%20or%20disabling%20stroke.%20%28Medtronic%20Evolut%20Transcatheter%20Aortic%20Valve%20Replacement%20in%20Low%20Risk%20Patients%3B%20NCT02701283%29.%22%2C%22date%22%3A%222023-05-02%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.jacc.2023.02.017%22%2C%22ISSN%22%3A%221558-3597%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22BJSZ96GT%22%2C%222K4N54U2%22%2C%22BNSCCUCI%22%5D%2C%22dateModified%22%3A%222023-06-08T14%3A04%3A28Z%22%7D%7D%2C%7B%22key%22%3A%2277U2UHFA%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gao%20et%20al.%22%2C%22parsedDate%22%3A%222023-04-29%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGao%2C%20F.%2C%20Kherallah%2C%20R.%2C%20Koetting%2C%20M.%20et%20al.%20%282023%29.%20Leadless%20pacemaker%20with%20transcatheter%20aortic%20valve%20implantation%3A%20A%20single-center%20experience.%20%26lt%3Bi%26gt%3BPacing%20Clin%20Electrophysiol%26lt%3B%5C%2Fi%26gt%3B.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fpace.14702%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1111%5C%2Fpace.14702%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Leadless%20pacemaker%20with%20transcatheter%20aortic%20valve%20implantation%3A%20A%20single-center%20experience%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Feng%22%2C%22lastName%22%3A%22Gao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Riyad%22%2C%22lastName%22%3A%22Kherallah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mackenzie%22%2C%22lastName%22%3A%22Koetting%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%22%2C%22lastName%22%3A%22Seger%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srikanth%22%2C%22lastName%22%3A%22Koneru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ourania%22%2C%22lastName%22%3A%22Preventza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vicente%22%2C%22lastName%22%3A%22Orozco-Sevilla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nastasya%22%2C%22lastName%22%3A%22Manon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20V.%22%2C%22lastName%22%3A%22Silva%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20The%20safety%20and%20efficacy%20of%20leadless%20pacemakers%20%28LP%29%20in%20transcatheter%20aortic%20valve%20implant%20%28TAVI%29%20patients%20is%20not%20well%20known%20due%20to%20paucity%20of%20data.%20Herein%2C%20we%20compared%20outcomes%20between%20leadless%20pacemakers%20to%20traditional%20dual%20chamber%20pacemakers%20%28DCP%29%20following%20TAVI.%5CnMETHODS%3A%20A%20single-center%20retrospective%20study%20was%20conducted%2C%20including%20a%20total%20of%2027%20patients%20with%20LP%20and%2033%20patients%20with%20DCP%20after%20TAVI%20between%20November%202013%20and%20May%202021.%20We%20compared%20baseline%20demographics%2C%20pacemaker%20indications%2C%20complication%20rates%2C%20percent%20pacing%2C%20and%20ejection%20fractions.%5CnRESULTS%3A%20Leading%20indications%20for%20pacemaker%20implant%20were%20complete%20heart%20block%20%2874%25%20LP%2C%2073%25%20DCP%29%20and%20high%20degree%20atrioventricular%20block%20%2826%25%20LP%2C%2021%25%20DCP%29.%20Twenty-two%20%2882%25%29%20LP%20patients%20had%20devices%20implanted%20in%20the%20right%20ventricular%20septal-apex.%20Three%20%289%25%29%20DCP%20patients%20required%20rehospitalization%20for%20pocket%20related%20complications.%20Zero%20pacemaker-related%20mortality%20was%20observed%20in%20both%20groups.%20Frequency%20of%20ventricular%20pacing%20and%20ejection%20fraction%20was%20similar%20between%20LP%20and%20DCP%20groups.%5CnCONCLUSION%3A%20From%20this%20single-center%20retrospective%20study%2C%20LP%20implant%20was%20feasible%20following%20TAVI%20and%20was%20found%20to%20have%20comparable%20performance%20to%20DCPs.%20LPs%20may%20be%20a%20reasonable%20alternative%20in%20TAVI%20patients%20where%20single%20ventricular%20pacing%20is%20indicated.%20Larger%20studies%20are%20required%20to%20validate%20these%20findings.%22%2C%22date%22%3A%222023-04-29%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1111%5C%2Fpace.14702%22%2C%22ISSN%22%3A%221540-8159%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22SQD2CTYV%22%2C%22BJSZ96GT%22%2C%22DJYFUK6T%22%2C%22AAQ89W3S%22%2C%222K4N54U2%22%2C%22KRWEJ8EU%22%2C%22MZXU6P62%22%2C%22NTAHPDUG%22%2C%22FKNSPK49%22%5D%2C%22dateModified%22%3A%222023-07-21T18%3A44%3A29Z%22%7D%7D%2C%7B%22key%22%3A%22YYDN7TAR%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Hamid%20et%20al.%22%2C%22parsedDate%22%3A%222023-03-22%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BHamid%2C%20N.%2C%20Jorde%2C%20U.%20P.%2C%20Reisman%2C%20M.%20et%20al.%20%282023%29.%20Transcatheter%20left%20ventricular%20restoration%20in%20patients%20with%20heart%20failure.%20%26lt%3Bi%26gt%3BJ%20Card%20Fail%26lt%3B%5C%2Fi%26gt%3B%2C%20S1071-9164%2823%2900070%26%23x2013%3B2.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cardfail.2023.03.003%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.cardfail.2023.03.003%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transcatheter%20left%20ventricular%20restoration%20in%20patients%20with%20heart%20failure%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nadira%22%2C%22lastName%22%3A%22Hamid%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ulrich%20P.%22%2C%22lastName%22%3A%22Jorde%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Reisman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Azeem%22%2C%22lastName%22%3A%22Latib%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22D.%20Scott%22%2C%22lastName%22%3A%22Lim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Susan%20M.%22%2C%22lastName%22%3A%22Joseph%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Alena%22%2C%22lastName%22%3A%22Kurlianskaya%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Oleg%22%2C%22lastName%22%3A%22Polonetsky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Petr%22%2C%22lastName%22%3A%22Neuzil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivek%22%2C%22lastName%22%3A%22Reddy%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jason%22%2C%22lastName%22%3A%22Foerst%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hemal%22%2C%22lastName%22%3A%22Gada%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kendra%20J.%22%2C%22lastName%22%3A%22Grubb%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dean%22%2C%22lastName%22%3A%22Kereiakes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Satya%22%2C%22lastName%22%3A%22Shreenivas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sean%22%2C%22lastName%22%3A%22Pinney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giedrius%22%2C%22lastName%22%3A%22Davidavicius%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Paul%22%2C%22lastName%22%3A%22Sorajja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22John%20P.%22%2C%22lastName%22%3A%22Boehmer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Franz%20X.%22%2C%22lastName%22%3A%22Kleber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patrick%22%2C%22lastName%22%3A%22Perier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%20M.%22%2C%22lastName%22%3A%22VAN%20Mieghem%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Dumonteil%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20B.%22%2C%22lastName%22%3A%22Leon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Daniel%22%2C%22lastName%22%3A%22Burkhoff%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Left%20ventricular%20%28LV%29%20volume%20reshaping%20reduces%20myocardial%20wall%20stress%20and%20may%20induce%20reverse%20remodeling%20in%20patients%20with%20heart%20failure%20with%20reduced%20ejection%20fraction.%20The%20AccuCinch%20Transcatheter%20Left%20Ventricular%20Restoration%20system%20consists%20of%20a%20series%20of%20anchors%20connected%20by%20a%20cable%20implanted%20along%20the%20LV%20base%20that%20is%20cinched%20to%20the%20basal%20free%20wall%20radius.%20We%20evaluated%20the%20echocardiographic%20and%20clinical%20outcomes%20following%20transcatheter%20left%20ventricular%20restoration.%5CnMETHODS%20AND%20RESULTS%3A%20We%20analyzed%2051%20heart%20failure%20patients%20with%20a%20left%20ventricular%20ejection%20fraction%20between%2020%25%20and%2040%25%2C%20with%20no%20more%20than%202%2B%20mitral%20regurgitation%20treated%20with%20optimal%20medical%20therapy%2C%20who%20subsequently%20underwent%20transcatheter%20left%20ventricular%20restoration.%20Serial%20echocardiograms%2C%20Kansas%20City%20Cardiomyopathy%20Questionnaire%20scores%2C%20and%206-minute%20walk%20test%20distances%20were%20measured%20at%20baseline%20through%2012%20months.%20Primary%20analysis%20end%20point%20was%20change%20in%20end-diastolic%20volume%20at%2012%20months%20compared%20with%20baseline.%20Patients%20%28n%5Cu202f%3D%5Cu202f51%29%20were%20predominantly%20male%20%2886%25%29%20with%20a%20mean%20age%20of%2056.3%20%5Cu00b1%2013.1%20years.%20Fluoroscopy%20showed%20LV%20free%20wall%20radius%20decreased%20by%20a%20median%20of%209.2%20mm%20amounting%20to%20a%2029.6%25%20decrease%20in%20the%20free%20wall%20arc%20length.%20At%2012%20months%2C%20the%20LV%20end-diastolic%20volume%20decreased%20by%2033.6%20%5Cu00b1%2034.8%20mL%20%28P%20%26lt%3B%20.01%29%2C%20with%20comparable%20decreases%20in%20the%20LV%20end-systolic%20volume.%20These%20decreases%20were%20associated%20with%20significant%20improvements%20in%20the%20overall%20Kansas%20City%20Cardiomyopathy%20Questionnaire%20score%20%2816.4%20%5Cu00b1%2018.7%20points%3B%20P%20%26lt%3B%20.01%29%20and%206-minute%20hall%20walk%20test%20distance%20%2845.9%20%5Cu00b1%2083.9%20m%3B%20P%20%26lt%3B%20.01%29.%20There%20were%20no%20periprocedural%20deaths%3B%20through%20the%201-year%20follow-up%2C%201%20patient%20died%20%28day%20280%29%20and%201%20patient%20received%20a%20left%20ventricular%20assist%20device%20%28day%2013%29.%5CnCONCLUSIONS%3A%20In%20patients%20with%20heart%20failure%20with%20reduced%20ejection%20fraction%20without%20significant%20mitral%20regurgitation%20receiving%20optimal%20medical%20therapy%2C%20the%20AccuCinch%20System%20resulted%20in%20decreases%20of%20LV%20volume%2C%20as%20well%20as%20improved%20quality%20of%20life%20and%20exercise%20endurance.%20A%20randomized%20trial%20is%20ongoing%20%28NCT04331769%29.%22%2C%22date%22%3A%222023-03-22%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.cardfail.2023.03.003%22%2C%22ISSN%22%3A%221532-8414%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%222K4N54U2%22%2C%22NTAHPDUG%22%5D%2C%22dateModified%22%3A%222023-06-08T18%3A05%3A51Z%22%7D%7D%2C%7B%22key%22%3A%22KMJNS6GU%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Patel%20et%20al.%22%2C%22parsedDate%22%3A%222022-06%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BPatel%2C%20V.%2C%20Gray%2C%20Z.%2C%20Alam%2C%20M.%20et%20al.%20%282022%29.%20Peripheral%20extracorporeal%20membrane%20oxygenation%20support%20expands%20the%20application%20of%20robot-assisted%20coronary%20artery%20bypass.%20%26lt%3Bi%26gt%3BJTCVS%20Tech%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B13%26lt%3B%5C%2Fi%26gt%3B%2C%2092%26%23x2013%3B100.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.xjtc.2022.02.034%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.xjtc.2022.02.034%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Peripheral%20extracorporeal%20membrane%20oxygenation%20support%20expands%20the%20application%20of%20robot-assisted%20coronary%20artery%20bypass%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivek%22%2C%22lastName%22%3A%22Patel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zachary%22%2C%22lastName%22%3A%22Gray%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahboob%22%2C%22lastName%22%3A%22Alam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20Vianna%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kenneth%22%2C%22lastName%22%3A%22Liao%22%7D%5D%2C%22abstractNote%22%3A%22OBJECTIVE%3A%20Robot-assisted%20coronary%20artery%20bypass%20%28RCAB%29%20is%20typically%20not%20offered%20to%20higher%20risk%20patients%20with%20reduced%20cardiopulmonary%20function%2C%20critical%20coronary%20artery%20disease%2C%20and%20challenging%20chest%20wall%20anatomy.%20In%20this%20study%2C%20we%20report%20the%20novel%20use%20of%20nonemergency%20intraoperative%20peripheral%20extracorporeal%20membrane%20oxygenation%20as%20partial%20cardiopulmonary%20support%20during%20RCAB%20for%20patients%20who%20were%20considered%20high-risk%20candidates%20for%20conventional%20CAB%20and%20at%20the%20same%20time%20not%20eligible%20for%20RCAB%20without%20cardiopulmonary%20support.%5CnMETHODS%3A%20Forty-five%20high%20risk%20patients%20%28mean%20age%2C%2068%5Cu00a0years%3B%20Society%20of%20Thoracic%20Surgeons%20score%2C%206.27%25%3B%20ejection%20fraction%2C%2045%25%29%20underwent%20RCAB%20with%20nonemergency%20peripheral%20extracorporeal%20membrane%20oxygenation%20support%20for%20the%20following%20indications%3A%20inability%20to%20tolerate%20single-lung%20ventilation%20%28n%5Cu00a0%3D%5Cu00a017%3B%2038%25%29%2C%20low%20ejection%20fraction%20%26lt%3B35%25%20%28n%5Cu00a0%3D%5Cu00a017%3B%2038%25%29%2C%20inadequate%20exposure%20of%20internal%20thoracic%20artery%20%28n%5Cu00a0%3D%5Cu00a024%3B%2053%25%29%2C%20critical%20coronary%20artery%20disease%20%28n%5Cu00a0%3D%5Cu00a016%3B%2036%25%29%2C%20and%20hemodynamic%20instability%20after%20anesthesia%20induction%20%28n%5Cu00a0%3D%5Cu00a03%3B%207%25%29.%20Following%20robotic%20internal%20thoracic%20artery%20takedown%2C%20all%20patients%20had%20beating%20heart%20minimally%20invasive%20direct%20CAB%20through%20a%202-inch%20minithoracotomy.%5CnRESULTS%3A%20Up%20to%2030%5Cu00a0days%2C%20there%20were%20no%20strokes%20%280%25%29%2C%20myocardial%20infarctions%20%280%25%29%2C%20or%20access%20vessel%20complications%20%280%25%29.%20One%20noncardiac%20related%20mortality%20%282.2%25%29%20was%20related%20to%20hemodialysis%20access%20issues%20in%20a%20patient%20with%20preexisting%20end-stage%20renal%20disease.%20One%20redo-CAB%20%282.2%25%29%20patient%20required%20sternotomy%20to%20locate%20the%20target%20vessel.%20Thirty-four%20%2875.6%25%29%20patients%20were%20extubated%20within%206%5Cu00a0hours%20of%20surgery.%5CnCONCLUSIONS%3A%20Our%20results%20examine%20the%20feasibility%20of%20using%20peripheral%20extracorporeal%20membrane%20oxygenation%20during%20RCAB%20for%20high-risk%20patients%20who%20otherwise%20had%20limited%20options.%20The%20use%20of%20peripheral%20extracorporeal%20membrane%20oxygenation%20in%20RCAB%20can%20potentially%20expand%20the%20surgical%20treatment%20options%20in%20high-risk%20coronary%20artery%20disease%20patients.%22%2C%22date%22%3A%22Jun%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.xjtc.2022.02.034%22%2C%22ISSN%22%3A%222666-2507%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZL4RPFGU%22%2C%22AAQ89W3S%22%2C%222K4N54U2%22%2C%22C2VFJYPK%22%2C%22UWTRFEPH%22%2C%22FA6KSIY7%22%5D%2C%22dateModified%22%3A%222023-02-14T20%3A19%3A19Z%22%7D%7D%2C%7B%22key%22%3A%22TQTFA93M%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Shah%20et%20al.%22%2C%22parsedDate%22%3A%222022-01-31%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BShah%2C%20S.%20J.%2C%20Borlaug%2C%20B.%20A.%2C%20Chung%2C%20E.%20S.%20et%20al.%20%282022%29.%20Atrial%20shunt%20device%20for%20heart%20failure%20with%20preserved%20and%20mildly%20reduced%20ejection%20fraction%20%28REDUCE%20LAP-HF%20II%29%3A%20a%20randomised%2C%20multicentre%2C%20blinded%2C%20sham-controlled%20trial.%20%26lt%3Bi%26gt%3BLancet%26lt%3B%5C%2Fi%26gt%3B%2C%20S0140-6736%2822%2900016%26%23x2013%3B2.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS0140-6736%2822%2900016-2%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2FS0140-6736%2822%2900016-2%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Atrial%20shunt%20device%20for%20heart%20failure%20with%20preserved%20and%20mildly%20reduced%20ejection%20fraction%20%28REDUCE%20LAP-HF%20II%29%3A%20a%20randomised%2C%20multicentre%2C%20blinded%2C%20sham-controlled%20trial%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sanjiv%20J.%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Barry%20A.%22%2C%22lastName%22%3A%22Borlaug%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eugene%20S.%22%2C%22lastName%22%3A%22Chung%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Donald%20E.%22%2C%22lastName%22%3A%22Cutlip%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philippe%22%2C%22lastName%22%3A%22Debonnaire%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peter%20S.%22%2C%22lastName%22%3A%22Fail%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qi%22%2C%22lastName%22%3A%22Gao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gerd%22%2C%22lastName%22%3A%22Hasenfu%5Cu00df%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rami%22%2C%22lastName%22%3A%22Kahwash%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20M.%22%2C%22lastName%22%3A%22Kaye%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheldon%20E.%22%2C%22lastName%22%3A%22Litwin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Philipp%22%2C%22lastName%22%3A%22Lurz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20M.%22%2C%22lastName%22%3A%22Massaro%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Rajeev%20C.%22%2C%22lastName%22%3A%22Mohan%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%20J.%22%2C%22lastName%22%3A%22Ricciardi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Scott%20D.%22%2C%22lastName%22%3A%22Solomon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Aaron%20L.%22%2C%22lastName%22%3A%22Sverdlov%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vijendra%22%2C%22lastName%22%3A%22Swarup%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dirk%20J.%22%2C%22lastName%22%3A%22van%20Veldhuisen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sebastian%22%2C%22lastName%22%3A%22Winkler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Martin%20B.%22%2C%22lastName%22%3A%22Leon%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22REDUCE%20LAP-HF%20II%20investigators%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Placement%20of%20an%20interatrial%20shunt%20device%20reduces%20pulmonary%20capillary%20wedge%20pressure%20during%20exercise%20in%20patients%20with%20heart%20failure%20and%20preserved%20or%20mildly%20reduced%20ejection%20fraction.%20We%20aimed%20to%20investigate%20whether%20an%20interatrial%20shunt%20can%20reduce%20heart%20failure%20events%20or%20improve%20health%20status%20in%20these%20patients.%5CnMETHODS%3A%20In%20this%20randomised%2C%20international%2C%20blinded%2C%20sham-controlled%20trial%20performed%20at%2089%20health-care%20centres%2C%20we%20included%20patients%20%28aged%20%5Cu226540%20years%29%20with%20symptomatic%20heart%20failure%2C%20an%20ejection%20fraction%20of%20at%20least%2040%25%2C%20and%20pulmonary%20capillary%20wedge%20pressure%20during%20exercise%20of%20at%20least%2025%20mm%20Hg%20while%20exceeding%20right%20atrial%20pressure%20by%20at%20least%205%20mm%20Hg.%20Patients%20were%20randomly%20assigned%20%281%3A1%29%20to%20receive%20either%20a%20shunt%20device%20or%20sham%20procedure.%20Patients%20and%20outcome%20assessors%20were%20masked%20to%20randomisation.%20The%20primary%20endpoint%20was%20a%20hierarchical%20composite%20of%20cardiovascular%20death%20or%20non-fatal%20ischemic%20stroke%20at%2012%20months%2C%20rate%20of%20total%20heart%20failure%20events%20up%20to%2024%20months%2C%20and%20change%20in%20Kansas%20City%20Cardiomyopathy%20Questionnaire%20overall%20summary%20score%20at%2012%20months.%20Pre-specified%20subgroup%20analyses%20were%20conducted%20for%20the%20heart%20failure%20event%20endpoint.%20Analysis%20of%20the%20primary%20endpoint%2C%20all%20other%20efficacy%20endpoints%2C%20and%20safety%20endpoints%20was%20conducted%20in%20the%20modified%20intention-to-treat%20population%2C%20defined%20as%20all%20patients%20randomly%20allocated%20to%20receive%20treatment%2C%20excluding%20those%20found%20to%20be%20ineligible%20after%20randomisation%20and%20therefore%20not%20treated.%20This%20study%20is%20registered%20with%20ClinicalTrials.gov%2C%20NCT03088033.%5CnFINDINGS%3A%20Between%20May%2025%2C%202017%2C%20and%20July%2024%2C%202020%2C%201072%20participants%20were%20enrolled%2C%20of%20whom%20626%20were%20randomly%20assigned%20to%20either%20the%20atrial%20shunt%20device%20%28n%3D314%29%20or%20sham%20procedure%20%28n%3D312%29.%20There%20were%20no%20differences%20between%20groups%20in%20the%20primary%20composite%20endpoint%20%28win%20ratio%201%5Cu00b70%20%5B95%25%20CI%200%5Cu00b78-1%5Cu00b72%5D%3B%20p%3D0%5Cu00b785%29%20or%20in%20the%20individual%20components%20of%20the%20primary%20endpoint.%20The%20prespecified%20subgroups%20demonstrating%20a%20differential%20effect%20of%20atrial%20shunt%20device%20treatment%20on%20heart%20failure%20events%20were%20pulmonary%20artery%20systolic%20pressure%20at%2020W%20of%20exercise%20%28pinteraction%3D0%5Cu00b7002%20%5B%26gt%3B70%20mm%20Hg%20associated%20with%20worse%20outcomes%5D%29%2C%20right%20atrial%20volume%20index%20%28pinteraction%3D0%5Cu00b7012%20%5B%5Cu226529%5Cu00b77%20mL%5C%2Fm2%2C%20worse%20outcomes%5D%29%2C%20and%20sex%20%28pinteraction%3D0%5Cu00b702%20%5Bmen%2C%20worse%20outcomes%5D%29.%20There%20were%20no%20differences%20in%20the%20composite%20safety%20endpoint%20between%20the%20two%20groups%20%28n%3D116%20%5B38%25%5D%20for%20shunt%20device%20vs%20n%3D97%20%5B31%25%5D%20for%20sham%20procedure%3B%20p%3D0%5Cu00b711%29.%5CnINTERPRETATION%3A%20Placement%20of%20an%20atrial%20shunt%20device%20did%20not%20reduce%20the%20total%20rate%20of%20heart%20failure%20events%20or%20improve%20health%20status%20in%20the%20overall%20population%20of%20patients%20with%20heart%20failure%20and%20ejection%20fraction%20of%20greater%20than%20or%20equal%20to%2040%25.%5CnFUNDING%3A%20Corvia%20Medical.%22%2C%22date%22%3A%22Jan%2031%202022%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2FS0140-6736%2822%2900016-2%22%2C%22ISSN%22%3A%221474-547X%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%229FBUJBMU%22%2C%22AAQ89W3S%22%2C%222K4N54U2%22%2C%22S7WF6DG3%22%2C%22WC4XX237%22%5D%2C%22dateModified%22%3A%222022-02-25T20%3A26%3A12Z%22%7D%7D%2C%7B%22key%22%3A%22EFZ9YY7A%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kherallah%20et%20al.%22%2C%22parsedDate%22%3A%222021-09%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKherallah%2C%20R.%20Y.%2C%20Koneru%2C%20S.%2C%20Krajcer%2C%20Z.%20et%20al.%20%282021%29.%20Hemodynamic%20outcomes%20after%20valve-in-valve%20transcatheter%20aortic%20valve%20replacement%3A%20a%20single-center%20experience.%20%26lt%3Bi%26gt%3BAnn%20Cardiothorac%20Surg%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B10%26lt%3B%5C%2Fi%26gt%3B%2C%20630%26%23x2013%3B640.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21037%5C%2Facs-2021-tviv-131%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.21037%5C%2Facs-2021-tviv-131%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Hemodynamic%20outcomes%20after%20valve-in-valve%20transcatheter%20aortic%20valve%20replacement%3A%20a%20single-center%20experience%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20Yazan%22%2C%22lastName%22%3A%22Kherallah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srikanth%22%2C%22lastName%22%3A%22Koneru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zvonimir%22%2C%22lastName%22%3A%22Krajcer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ourania%22%2C%22lastName%22%3A%22Preventza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20G.%22%2C%22lastName%22%3A%22Dougherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Melissa%20L.%22%2C%22lastName%22%3A%22McCormack%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Briana%20T.%22%2C%22lastName%22%3A%22Costello%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%22%2C%22lastName%22%3A%22Coulter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%20E.%22%2C%22lastName%22%3A%22Strickman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Carlos%22%2C%22lastName%22%3A%22Plana%20Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Mortazavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jose%20G.%22%2C%22lastName%22%3A%22D%5Cu00edez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20J.%22%2C%22lastName%22%3A%22Livesay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20S.%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20V.%22%2C%22lastName%22%3A%22Silva%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Sept%202021%22%2C%22language%22%3A%22%22%2C%22DOI%22%3A%2210.21037%5C%2Facs-2021-tviv-131%22%2C%22ISSN%22%3A%222225319X%2C%2023041021%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.annalscts.com%5C%2Farticle%5C%2Fview%5C%2F16858%5C%2Fhtml%22%2C%22collections%22%3A%5B%22DV9ZHE2J%22%2C%223WHLRQCH%22%2C%22SQD2CTYV%22%2C%22BJSZ96GT%22%2C%22YL3LPZGE%22%2C%22Z2XX7DHR%22%2C%22M32R8FP2%22%2C%22YQ6XGPLC%22%2C%22RB8ZRZCJ%22%2C%222K4N54U2%22%2C%22QSVIJDTT%22%2C%22MZXU6P62%22%2C%228PULYTSK%22%5D%2C%22dateModified%22%3A%222022-05-12T20%3A43%3A50Z%22%7D%7D%2C%7B%22key%22%3A%223SXXRRI8%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Kherallah%20et%20al.%22%2C%22parsedDate%22%3A%222021-04-15%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BKherallah%2C%20R.%20Y.%2C%20Harrison%2C%20D.%2C%20Preventza%2C%20O.%20et%20al.%20%282021%29.%20Transcatheter%20aortic%20valve%20replacement%20after%20chest%20radiation%3A%20A%20propensity-matched%20analysis.%20%26lt%3Bi%26gt%3BInt%20J%20Cardiol%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B329%26lt%3B%5C%2Fi%26gt%3B%2C%2050%26%23x2013%3B55.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijcard.2020.12.054%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.ijcard.2020.12.054%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Transcatheter%20aortic%20valve%20replacement%20after%20chest%20radiation%3A%20A%20propensity-matched%20analysis%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Riyad%20Y.%22%2C%22lastName%22%3A%22Kherallah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Darren%22%2C%22lastName%22%3A%22Harrison%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ourania%22%2C%22lastName%22%3A%22Preventza%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20V.%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kathryn%20G.%22%2C%22lastName%22%3A%22Dougherty%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephanie%20A.%22%2C%22lastName%22%3A%22Coulter%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leo%22%2C%22lastName%22%3A%22Simpson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Neil%20E.%22%2C%22lastName%22%3A%22Strickman%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ali%22%2C%22lastName%22%3A%22Mortazavi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Palaskas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Richard%20D.%22%2C%22lastName%22%3A%22Fish%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zvonimir%22%2C%22lastName%22%3A%22Krajcer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%20F.%22%2C%22lastName%22%3A%22Stainback%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Carlos%20Plana%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22James%20J.%22%2C%22lastName%22%3A%22Livesay%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%20S.%22%2C%22lastName%22%3A%22Coselli%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srikanth%22%2C%22lastName%22%3A%22Koneru%22%7D%5D%2C%22abstractNote%22%3A%22BACKGROUND%3A%20Chest%20radiation%20therapy%20%28CRT%29%20for%20malignant%20thoracic%20neoplasms%20is%20associated%20with%20development%20of%20valvular%20heart%20disease%20years%20later.%20As%20previous%20radiation%20exposure%20can%20complicate%20surgical%20treatment%2C%20transcatheter%20aortic%20valve%20replacement%20%28TAVR%29%20has%20emerged%20as%20an%20alternative.%20However%2C%20outcomes%20data%20are%20lacking%20for%20TAVR%20patients%20with%20a%20history%20of%20CRT.%5CnMETHODS%3A%20We%20conducted%20a%20retrospective%20study%20of%20all%20patients%20who%20underwent%20a%20TAVR%20procedure%20at%20a%20single%20institution%20between%20September%202012%20and%20November%202018.%20Among%201341%20total%20patients%2C%2050%20had%20previous%20CRT.%20These%20were%20propensity-matched%20in%20a%201%3A2%20ratio%20to%20100%20patients%20without%20history%20of%20CRT.%20Thirty-day%20adverse%20events%20were%20analyzed%20with%20generalized%20estimating%20equation%20models.%20Overall%20mortality%20was%20analyzed%20with%20stratified%20Cox%20regression%20modelling.%5CnRESULTS%3A%20Median%20clinical%20follow-up%20was%2024%5Cu00a0months%20%28interquartile%20range%20%5BIQR%5D%2C%2012-44%5Cu00a0months%29.%20There%20was%20no%20difference%20between%20CRT%20and%20non-CRT%20patients%20in%20overall%20mortality%20%28hazard%20ratio%20%5BHR%5D%200.84%20%5B0.37-1.90%5D%2C%20P%5Cu00a0%3D%5Cu00a00.67%29%2C%2030-day%20mortality%20%28HR%203.1%20%5B0.49-20.03%5D%2C%20P%5Cu00a0%3D%5Cu00a00.23%29%2C%20or%2030-day%20readmission%20rate%20%28HR%201.0%20%5B0.43-2.31%5D%2C%20P%5Cu00a0%3D%5Cu00a01%29.%20There%20were%20no%20differences%20in%20the%20rates%20of%20most%20adverse%20events%2C%20but%20patients%20with%20CRT%20history%20had%20higher%20rates%20of%20postprocedural%20respiratory%20failure%20%28HR%203.63%20%5B1.32-10.02%5D%2C%20P%5Cu00a0%3D%5Cu00a00.01%29%20and%20permanent%20pacemaker%20implantation%20%28HR%202.84%20%5B1.15-7.01%5D%2C%20P%5Cu00a0%3D%5Cu00a00.02%29.%5CnCONCLUSIONS%3A%20For%20patients%20with%20aortic%20valve%20stenosis%20and%20previous%20CRT%2C%20TAVR%20is%20safe%20and%20effective%2C%20with%20outcomes%20similar%20to%20those%20in%20the%20general%20aortic%20stenosis%20population.%20Patients%20with%20history%20of%20CRT%20are%20more%20likely%20to%20have%20postprocedural%20respiratory%20failure%20and%20to%20require%20permanent%20pacemaker%20implantation.%22%2C%22date%22%3A%22Apr%2015%2C%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.ijcard.2020.12.054%22%2C%22ISSN%22%3A%221874-1754%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22DV9ZHE2J%22%2C%223WHLRQCH%22%2C%22SQD2CTYV%22%2C%22BJSZ96GT%22%2C%22YRK99JHR%22%2C%22Z2XX7DHR%22%2C%22M32R8FP2%22%2C%22AAQ89W3S%22%2C%22X6Y3USZ6%22%2C%22YQ6XGPLC%22%2C%22RB8ZRZCJ%22%2C%222K4N54U2%22%2C%22MZXU6P62%22%2C%228PULYTSK%22%2C%22MDTREPAF%22%5D%2C%22dateModified%22%3A%222022-11-04T15%3A27%3A39Z%22%7D%7D%2C%7B%22key%22%3A%224B7Q6I5D%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Nazir%20et%20al.%22%2C%22parsedDate%22%3A%222021-03-10%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BNazir%2C%20S.%2C%20Hahn%2C%20J.%2C%20Minhas%2C%20A.%20M.%20et%20al.%20%282021%29.%20Association%20of%20Type%202%20myocardial%20infarction%20with%20outcomes%20and%20resource%20utilization%20in%20patients%20undergoing%20endovascular%20transcatheter%20aortic%20valve%20replacement.%20%26lt%3Bi%26gt%3BCardiovasc%20Revasc%20Med%26lt%3B%5C%2Fi%26gt%3B%2C%20S1553-8389%2821%2900140%26%23x2013%3B8.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.carrev.2021.03.006%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.carrev.2021.03.006%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Association%20of%20Type%202%20myocardial%20infarction%20with%20outcomes%20and%20resource%20utilization%20in%20patients%20undergoing%20endovascular%20transcatheter%20aortic%20valve%20replacement%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salik%22%2C%22lastName%22%3A%22Nazir%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joshua%22%2C%22lastName%22%3A%22Hahn%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Abdul%20Mannan%22%2C%22lastName%22%3A%22Minhas%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Keerat%20Rai%22%2C%22lastName%22%3A%22Ahuja%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Juan%20Plana%22%2C%22lastName%22%3A%22Gomez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ernesto%22%2C%22lastName%22%3A%22Jimenez%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22George%20V.%22%2C%22lastName%22%3A%22Moukarbel%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hani%22%2C%22lastName%22%3A%22Jneid%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Mar%2010%202021%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.carrev.2021.03.006%22%2C%22ISSN%22%3A%221878-0938%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22M32R8FP2%22%2C%222K4N54U2%22%5D%2C%22dateModified%22%3A%222021-10-29T17%3A45%3A31Z%22%7D%7D%2C%7B%22key%22%3A%227SRXJVWK%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Mahtta%20et%20al.%22%2C%22parsedDate%22%3A%222020-08-08%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BMahtta%2C%20D.%2C%20Sudhakar%2C%20D.%2C%20Koneru%2C%20S.%20et%20al.%20%282020%29.%20Targeting%20inflammation%20after%20myocardial%20infarction.%20%26lt%3Bi%26gt%3BCurr%20Cardiol%20Rep%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B22%26lt%3B%5C%2Fi%26gt%3B%2C%20110.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11886-020-01358-2%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1007%5C%2Fs11886-020-01358-2%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeting%20inflammation%20after%20myocardial%20infarction%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhruv%22%2C%22lastName%22%3A%22Mahtta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Deepthi%22%2C%22lastName%22%3A%22Sudhakar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Srikanth%22%2C%22lastName%22%3A%22Koneru%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20Vianna%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mahboob%22%2C%22lastName%22%3A%22Alam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Salim%20S.%22%2C%22lastName%22%3A%22Virani%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hani%22%2C%22lastName%22%3A%22Jneid%22%7D%5D%2C%22abstractNote%22%3A%22PURPOSE%20OF%20REVIEW%3A%20Inflammation%20plays%20a%20key%20role%20in%20clearing%20cellular%20debris%20and%20recovery%20after%20acute%20myocardial%20infarction%20%28AMI%29.%20Dysregulation%20of%20or%20prolonged%20inflammation%20may%20result%20in%20adverse%20cardiac%20remodeling%20and%20major%20adverse%20clinical%20events%20%28MACE%29.%20Several%20pre-clinical%20studies%20and%20moderate%20sized%20clinical%20trials%20have%20investigated%20the%20role%20of%20immunomodulation%20in%20improving%20clinical%20outcomes%20in%20patients%20with%20AMI.%5CnRECENT%20FINDINGS%3A%20Clinical%20data%20from%20the%20Canakinumab%20Atherothrombosis%20Outcome%20%28CANTOS%29%20and%20Colchicine%20Cardiovascular%20Outcomes%20Trial%20%28COLCOT%29%20have%20provided%20encouraging%20results%20among%20patients%20with%20AMI.%20Several%20other%20clinical%20and%20pre-clinical%20trials%20have%20brought%20about%20the%20prospect%20of%20modulating%20inflammation%20at%20various%20junctures%20of%20the%20inflammatory%20cascade%20including%20inhibition%20of%20complement%20cascade%2C%20interleukins%2C%20and%20matrix%20metalloproteinases.%20In%20patients%20with%20AMI%2C%20modulation%20of%20residual%20inflammation%20via%20various%20inflammatory%20pathways%20and%20mediators%20may%20hold%20promise%20for%20further%20reducing%20MACE.%20Learning%20from%20current%20data%20and%20understanding%20the%20nuances%20of%20immunomodulation%20in%20AMI%20are%20key%20for%20future%20trials%20and%20before%20widespread%20dissemination%20of%20such%20therapies.%22%2C%22date%22%3A%22Aug%2008%2C%202020%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1007%5C%2Fs11886-020-01358-2%22%2C%22ISSN%22%3A%221534-3170%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22ZL4RPFGU%22%2C%222K4N54U2%22%5D%2C%22dateModified%22%3A%222020-09-15T17%3A28%3A57Z%22%7D%7D%2C%7B%22key%22%3A%225K79Z2QE%22%2C%22library%22%3A%7B%22id%22%3A4862227%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Gold%20et%20al.%22%2C%22parsedDate%22%3A%222019-10%22%2C%22numChildren%22%3A3%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%201.35%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3BGold%2C%20B.%20M.%2C%20Parekh%2C%20D.%20R.%2C%20Kearney%2C%20D.%20L.%20et%20al.%20%282019%29.%20Forme%20Fruste%20cor%20triatriatum%20dexter%20by%20transesophageal%20echocardiography%20and%20its%20impact%20on%20percutaneous%20heart%20procedures%3A%20a%20case%20series.%20%26lt%3Bi%26gt%3BCASE%20%28Phila%29%26lt%3B%5C%2Fi%26gt%3B%20%26lt%3Bi%26gt%3B3%26lt%3B%5C%2Fi%26gt%3B%2C%20189%26%23x2013%3B199.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.case.2019.05.004%26%23039%3B%26gt%3Bhttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1016%5C%2Fj.case.2019.05.004%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Forme%20Fruste%20cor%20triatriatum%20dexter%20by%20transesophageal%20echocardiography%20and%20its%20impact%20on%20percutaneous%20heart%20procedures%3A%20a%20case%20series%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Benjamin%20M.%22%2C%22lastName%22%3A%22Gold%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dhaval%20R.%22%2C%22lastName%22%3A%22Parekh%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Debra%20L.%22%2C%22lastName%22%3A%22Kearney%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guilherme%20V.%22%2C%22lastName%22%3A%22Silva%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22R.%20David%22%2C%22lastName%22%3A%22Fish%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Raymond%20F.%22%2C%22lastName%22%3A%22Stainback%22%7D%5D%2C%22abstractNote%22%3A%22%22%2C%22date%22%3A%22Oct%202019%22%2C%22language%22%3A%22eng%22%2C%22DOI%22%3A%2210.1016%5C%2Fj.case.2019.05.004%22%2C%22ISSN%22%3A%222468-6441%22%2C%22url%22%3A%22%22%2C%22collections%22%3A%5B%22YRK99JHR%22%2C%22X6Y3USZ6%22%2C%222K4N54U2%22%2C%22K6JKEATQ%22%2C%228PULYTSK%22%5D%2C%22dateModified%22%3A%222022-02-17T16%3A55%3A56Z%22%7D%7D%5D%7D
Forrest, J. K., Deeb, G. M., Yakubov, S. J. et al. (2023). 3-year outcomes after transcatheter or surgical aortic valve replacement in low-risk patients with aortic stenosis. J Am Coll Cardiol 81, 1663–1674. https://doi.org/10.1016/j.jacc.2023.02.017.
Gao, F., Kherallah, R., Koetting, M. et al. (2023). Leadless pacemaker with transcatheter aortic valve implantation: A single-center experience. Pacing Clin Electrophysiol. https://doi.org/10.1111/pace.14702.
Hamid, N., Jorde, U. P., Reisman, M. et al. (2023). Transcatheter left ventricular restoration in patients with heart failure. J Card Fail, S1071-9164(23)00070–2. https://doi.org/10.1016/j.cardfail.2023.03.003.
Patel, V., Gray, Z., Alam, M. et al. (2022). Peripheral extracorporeal membrane oxygenation support expands the application of robot-assisted coronary artery bypass. JTCVS Tech 13, 92–100. https://doi.org/10.1016/j.xjtc.2022.02.034.
Shah, S. J., Borlaug, B. A., Chung, E. S. et al. (2022). Atrial shunt device for heart failure with preserved and mildly reduced ejection fraction (REDUCE LAP-HF II): a randomised, multicentre, blinded, sham-controlled trial. Lancet, S0140-6736(22)00016–2. https://doi.org/10.1016/S0140-6736(22)00016-2.
Kherallah, R. Y., Koneru, S., Krajcer, Z. et al. (2021). Hemodynamic outcomes after valve-in-valve transcatheter aortic valve replacement: a single-center experience. Ann Cardiothorac Surg 10, 630–640. https://doi.org/10.21037/acs-2021-tviv-131.
Kherallah, R. Y., Harrison, D., Preventza, O. et al. (2021). Transcatheter aortic valve replacement after chest radiation: A propensity-matched analysis. Int J Cardiol 329, 50–55. https://doi.org/10.1016/j.ijcard.2020.12.054.
Nazir, S., Hahn, J., Minhas, A. M. et al. (2021). Association of Type 2 myocardial infarction with outcomes and resource utilization in patients undergoing endovascular transcatheter aortic valve replacement. Cardiovasc Revasc Med, S1553-8389(21)00140–8. https://doi.org/10.1016/j.carrev.2021.03.006.
Mahtta, D., Sudhakar, D., Koneru, S. et al. (2020). Targeting inflammation after myocardial infarction. Curr Cardiol Rep 22, 110. https://doi.org/10.1007/s11886-020-01358-2.
Gold, B. M., Parekh, D. R., Kearney, D. L. et al. (2019). Forme Fruste cor triatriatum dexter by transesophageal echocardiography and its impact on percutaneous heart procedures: a case series. CASE (Phila) 3, 189–199. https://doi.org/10.1016/j.case.2019.05.004.